Docetaxel, Cisplatin, and 5-FU Triplet Therapy as Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma

被引：0
|
作者：
Wing-Lok Chan
Cheuk-Wai Choi
Ian Yu-Hong Wong
Terence Hon-Ting Tsang
Adrian Tin-Chung Lam
Rosa Pui-Ying Tse
K. K. Chan
Claudia Wong
Betty Tze-Ting Law
Emina Edith Cheung
Siu-Yin Chan
Ka-On Lam
Dora Kwong
Simon Law
机构：
[1] The University of Hong Kong,Department of Clinical Oncology, LKS Faculty of Medicine
[2] The University of Hong Kong,School of Public Health, LKS Faculty of Medicine
[3] The University of Hong Kong,Department of Surgery, LKS Faculty of Medicine
[4] The University of Hong Kong,LKS Faculty of Medicine
[5] Queen Mary Hospital,Department of Clinical Oncology
[6] Queen Mary Hospital,Department of Surgery
来源：
Annals of Surgical Oncology | 2023年 / 30卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：861 / 870
页数：9
相关论文
共 50 条
  • [41] Investigation of operative outcomes of thoracoscopic esophagectomy after triplet chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for advanced esophageal squamous cell carcinoma
    Akiyama, Yuji
    Iwaya, Takeshi
    Endo, Fumitaka
    Chiba, Takehiro
    Takahara, Takeshi
    Otsuka, Koki
    Nitta, Hiroyuki
    Koeda, Keisuke
    Mizuno, Masaru
    Kimura, Yusuke
    Sasaki, Akira
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2018, 32 (01): : 391 - 399
  • [42] Phase II trial of docetaxel and cisplatin in 5-FU/cisplatin pretreated refractory esophageal cancer
    Shim, H.
    Bae, W.
    Hwang, J.
    Cho, S.
    Nam, T.
    Chung, I.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [43] Nimotuzumab Combined With Concurrent Chemoradiation Therapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma
    Zhai, Y. R.
    Hui, Z.
    Wang, X.
    Liang, J.
    Wang, W.
    Feng, Q.
    Zhou, Z.
    Wang, X.
    Xiao, Z.
    Bi, N.
    Wang, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E205 - E205
  • [44] Induction Therapy of Tislelizumab Combined with Cisplatin and 5-Fluorouracil and Subsequent Conversion Surgery in Patients with Unresectable Advanced Esophageal Squamous Cell Carcinoma: A Phase 2, Single Center Study
    Xu, Tongpeng
    Bai, Jianan
    Zhao, Kun
    Chen, Xiaofeng
    Wang, Shuhui
    Zhu, Shusheng
    Sun, Chongqi
    Zhao, Chenhui
    Wang, Ting
    Zhu, Ling
    Hu, Meizhen
    Pang, Fei
    Zhang, Junling
    Wang, Wei
    Shu, Yongqian
    Li, Fang
    Zhou, Yue
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (13) : 9321 - 9331
  • [45] A Phase I/II Study of Second-Line Chemotherapy with Fractionated Docetaxel and Nedaplatin for 5-FU/Cisplatin-Resistant Esophageal Squamous Cell Carcinoma
    Akutsu, Yasunori
    Shuto, Kiyohiko
    Kono, Tsuguaki
    Uesato, Masaya
    Hoshino, Isamu
    Shiratori, Toru
    Miyazawa, Yukimasa
    Isozaki, Yuka
    Akanuma, Naoki
    Matsubara, Hisahiro
    HEPATO-GASTROENTEROLOGY, 2012, 59 (119) : 2095 - 2098
  • [46] Neoadjuvant chemotherapy of triplet regimens of docetaxel/cisplatin/5-FU (DCF NAC) may improve patient prognosis of cStage II/III esophageal squamous cell carcinoma-propensity score analysis
    Keishi Yamashita
    Natsuya Katada
    Hiromitsu Moriya
    Kei Hosoda
    Hiroaki Mieno
    Chikatoshi Katada
    Wasaburo Koizumi
    Keika Hoshi
    Masahiko Watanabe
    General Thoracic and Cardiovascular Surgery, 2016, 64 : 209 - 215
  • [47] Neoadjuvant chemotherapy of triplet regimens of docetaxel/cisplatin/5-FU (DCF NAC) may improve patient prognosis of cStage II/III esophageal squamous cell carcinoma-propensity score analysis
    Yamashita, Keishi
    Katada, Natsuya
    Moriya, Hiromitsu
    Hosoda, Kei
    Mieno, Hiroaki
    Katada, Chikatoshi
    Koizumi, Wasaburo
    Hoshi, Keika
    Watanabe, Masahiko
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2016, 64 (04) : 209 - 215
  • [48] A phase II trial of neoadjuvant docetaxel/5-FU/cisplatin in combination with prophylactic pegteograstim in unresectable, locally advanced nasal cavity/paranasal squamous cell carcinoma: KCSG HN18-07
    An, Hojung
    Keam, Bhumsuk
    Shin, Seong Hoon
    Kim, Min Kyoung
    Kim, Sung-Bae
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [49] A RANDOMIZED TRIAL OF CISPLATIN (CACP) + 5-FLUOROURACIL (5-FU) INFUSION AND CACP + 5-FU BOLUS FOR RECURRENT AND ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    KISH, JA
    ENSLEY, JF
    JACOBS, J
    WEAVER, A
    CUMMINGS, G
    ALSARRAF, M
    CANCER, 1985, 56 (12) : 2740 - 2744
  • [50] A COMPARISON OF CISPLATIN 5-FU WITH CARBOPLATIN 5-FU FOR 5-YEAR SURVIVAL OF PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    EBELING, O
    ECKEL, HE
    VOLLING, P
    HEITMANN, K
    VOSSING, M
    HNO, 1994, 42 (10) : 629 - 635
12345